北京佰司特科技成功參加第17屆國際毒理學(xué)大會(huì)

第17屆國際毒理學(xué)大會(huì)（ICTXVII，ICT2025）于2025年10月15日至18日由國際毒理學(xué)聯(lián)合會(huì)（IUTOX）和中國毒理學(xué)會(huì)（CST）共同主辦。國際毒理學(xué)大會(huì)是由IUTOX每三年舉辦的一項(xiàng)重要的國際學(xué)術(shù)會(huì)議。作為分子生物學(xué)和類器官平臺(tái)的設(shè)備和服務(wù)商，北京佰司特科技受邀參加了本屆大會(huì)，在現(xiàn)場(chǎng)向參會(huì)者介紹了類器官串聯(lián)芯片培養(yǎng)系統(tǒng)、類器官代謝監(jiān)測(cè)儀，吸引了眾多參會(huì)老師前來交流咨詢。

第17屆國際毒理學(xué)大會(huì)（ICTXVII，ICT2025）于2025年10月15日至18日在中國北京國測(cè)國際會(huì)議中心舉行，大會(huì)由國際毒理學(xué)聯(lián)合會(huì)（IUTOX）和中國毒理學(xué)會(huì)（CST）共同主辦。國際毒理學(xué)大會(huì)是由IUTOX每三年舉辦的一項(xiàng)重要的國際學(xué)術(shù)會(huì)議，IUTOX的宗旨是促進(jìn)科學(xué)合作，推動(dòng)毒理學(xué)科學(xué)和技術(shù)的發(fā)展。迄今為止，已成功舉辦了16屆IUTOX國際大會(huì)。2019年7月在美國舉行的第15屆國際毒理學(xué)大會(huì)上，通過選舉，IUTOX決定第17屆國際毒理學(xué)大會(huì)將于2025年由中國毒理學(xué)會(huì)主辦。

大會(huì)邀請(qǐng)來自60余個(gè)國家/組織的毒理學(xué)相關(guān)領(lǐng)域?qū)＜遥脑O(shè)置41個(gè)專題分會(huì)場(chǎng)及研討會(huì)（workshop）；同時(shí)，還特設(shè)6個(gè)培訓(xùn)課程，以及壁報(bào)交流、科技展覽等多種互動(dòng)形式，為與會(huì)者搭建了一個(gè)方位、多維度的交流平臺(tái)。這不僅將極大地豐富毒理學(xué)的理論體系，更將有力推動(dòng)其創(chuàng)新發(fā)展，為健康科技與產(chǎn)業(yè)的蓬勃發(fā)展注入強(qiáng)勁動(dòng)力。

大會(huì)的議題包括（但不限于）環(huán)境毒理學(xué)、納米毒理學(xué)、臨床毒理學(xué)、表觀遺傳毒理學(xué)、生物化學(xué)和分子毒理學(xué)、工業(yè)毒理學(xué)和化學(xué)損傷、分析毒理學(xué)、遺傳毒性和致癌性評(píng)估、重金屬毒性及其相關(guān)疾病、計(jì)算毒理學(xué)、靶器官毒性及其分子機(jī)制、藥物和食品安全及風(fēng)險(xiǎn)評(píng)估、中藥和天然藥物的毒理學(xué)、替代毒理學(xué)方法、下一代風(fēng)險(xiǎn)評(píng)估（NGRA）、新方法學(xué)（NAMs）及其在毒理學(xué)中的應(yīng)用、新能源的安全性評(píng)估、大數(shù)據(jù)和人工智能、器官芯片和3D打印、毒理學(xué)與毒物組學(xué)、高通量分析、毒性途徑和不良后果途徑等。

一、基本信息

時(shí)間：2025年10月15日至18日

地點(diǎn)：中國北京國測(cè)國際會(huì)展中心

主題：毒理學(xué)促進(jìn)安全環(huán)境和健康生活

二、日程安排

三、分會(huì)場(chǎng)主題

Symposium：

1.Cross-sector replacement, reduction and refinement of acute toxicity tests

2.Organoids and organ-on-a-chip in Toxicology

3.Toxicity of opioids: new insights to understand and face the progressing threat

4.Pesticide and herbicide exposure: from risk assessment to morbi-mortality reduction

5.Assessing the exposure and toxicity of emerging toxicants in humans

6.Advancements in Reproductive Toxicology

7.Mapping Human Immune Development and New Approach Methodologies to Test its Vulnerability to Toxicants

8.Relevance of non-genotoxic mechanistic endpoints in different test systems for the evidence-based evaluation of carcinogenic hazards

9.Environmental genotoxic effects: DNA damage response and cell death signaling

10.RNA dysregulations and environmental carcinogenesis

11.Systemic and next generation toxic effects of inhaled carbonaceous ultrafine particles

12.The Serious Issue of Interference in Nanotoxicology

13.Airborne Micro- and Nanoplastics: Comprehensive Overview of Exposure, Toxicity and Risk Mitigation Strategies

14.Air pollutants and PM2.5 - chemical composition and health consequences.

15.Frontiers in Environmental Toxicology on Emerging Pollutants

16.Genetic toxicology, stem cell toxicology and nanotoxicology

17.Modernising approaches to safety assessment through use of in silico approaches in decision-making

18.PARC- new approaches to model kinetic properties

19.Towards next generation probabilistic risk assessment propelled by artificial intelligence and quantitative mode-of-action ontologies.

20.Thresholds of Toxicological Concern – recent developments across regions and at the interface with computational modelling

21.Toxicities from traditional pharmaceutical drugs: new insights into  the mechanisms and therapeutic approaches

22.Mechanisms of immune system toxicity and therapeutic approaches for modifying disease

23.Clinical Translation and Practice of Hepatic Toxicology

24.Challenges and Opportunities in Translating Microphysiological Systems to Regulatory Decisions

25.The Westward Movement of Botanicals

26.Safety assessments for dietary supplements and herbal products 

27.The science, application and management in risk assessment

28.Safety of Recycled Plastic for Food Packaging

29.AI-Empowered Environmental Computational Toxicology

30.Novel Strategies for Safety Assessment: A Paradigm Shift for the Future

31．Next generation risk assessment

Workshop：

32.Application of synchrotron radiation techniques in Toxicology

33.Drug toxicology and drug safety evaluation

34.Heavy Metal Toxicity and Human Health

35.Understanding and Mitigating Occupational Heavy Metal Exposure: A Comprehensive Approach

36.High-throughput technology and health effects of heavy metal

37.Joining Forces Towards The Human Exposome Project

38.Strategic Assessment and Prioritization of Chemicals for Hazard and Risk Assessment

39.Unlocking the Future of Safety: New Approach Methodologies (NAMs) and Next Generation Risk Assessment (NGRA)

40.Gen AI in scientific publishing

41.Aquatic organisms as models for toxicity evaluation of emergent pollutants

42.Unique Challenges and Strategies for New Modalities Across Bioanalytical, DMPK, Toxicology, and Regulatory Affairs

Continuing Education Course：

43.Advancing Scientific Excellence and Increasing Confidence in NAMs through Good In Vitro Method Practices (GIVIMP)

44.Episkin Academy Training

45.From the Past to the Present: Does Particle Toxicology Really Change?

46.The emerging psychoactive drugs: epidemiology, consumption modes, and toxicities

47.Utilizing Computational Methods and Tools for Inferring and Predicting Reference Dose (RfD) in Chemical Risk Assessment

48.Advanced Toxicological Topics for Study Directors of Nonclinical Studies

北京佰司特科技有限責(zé)任公司作為第十七屆國際毒理學(xué)大會(huì)（ICTXVII）的贊助商，深度契合大會(huì) “毒理學(xué)促進(jìn)安全環(huán)境和健康生活" 的核心主題，公司聚焦大會(huì) “器官芯片與類器官毒理學(xué)"“新方法學(xué)（NAMs）應(yīng)用" 等核心議題， “雙引擎"體外類器官研究?jī)x器，通過精準(zhǔn)模擬體內(nèi)血流動(dòng)力學(xué)與器官交互，動(dòng)態(tài)追蹤微塑料、納米顆粒等新興污染物的跨器官毒性傳導(dǎo)，解決傳統(tǒng)模型種屬差異與靜態(tài)培養(yǎng)局限，介紹了類器官培養(yǎng)技術(shù)和監(jiān)測(cè)分析技術(shù)在環(huán)境污染物與藥物毒性評(píng)估中的價(jià)值。

北京佰司特科技有限責(zé)任公司在本次大會(huì)現(xiàn)場(chǎng)，系統(tǒng)呈現(xiàn)了類器官串聯(lián)芯片培養(yǎng)系技術(shù)和類器官代謝分析技術(shù)等平臺(tái)，助力研究者高效開展環(huán)境毒理學(xué)、靶器官毒性等領(lǐng)域研究。北京佰司特科技的技術(shù)人員為前來咨詢的參會(huì)老師介紹產(chǎn)品信息、技術(shù)特點(diǎn)優(yōu)勢(shì)等，通過了解需求并快速給出針對(duì)性的解決方案，和參會(huì)老師積極互動(dòng)、廣泛探討、深入交流，專業(yè)的知識(shí)儲(chǔ)備和熱情的講解受到了大家的歡迎。

近 10 年來類器官技術(shù)作為生物學(xué)和臨床醫(yī)學(xué)熱門的前沿技術(shù)之一，備受醫(yī)學(xué)科研領(lǐng)域的關(guān)注。目前類器官技術(shù)在疾病研究、腫瘤藥敏、臨床免疫、藥物毒理、再生醫(yī)學(xué)等多學(xué)科領(lǐng)域中展現(xiàn)出獨(dú)特的優(yōu)勢(shì)，已成為臨床研究和新藥研發(fā)具潛力的研究工具之一。